Vanguard Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.81M Buy
22,987
+2,239
+11% +$156K ﹤0.01% 1602
2026
Q2
$1.31M Hold
20,748
– – ﹤0.01% 1756
2026
Q1
$1.46M Buy
+20,748
New +$1.45M ﹤0.01% 1608

Other funds holding TARS

Vanguard Asset Management's TARS Position: Q3 2026 in Review

Vanguard Asset Management increased its Tarsus Pharmaceuticals (TARS) stake by 11% in Q3 2026, buying an estimated $156K and bringing the position to 22,987 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Vanguard Asset Management first reported a position in TARS in Q1 2026 and has held it in 3 quarters since. 176 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Vanguard Asset Management held 22,987 shares of Tarsus Pharmaceuticals worth $1.81M as of Q3 2026.
  • Vanguard Asset Management bought 2,239 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $156K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1602 holding.
  • Vanguard Asset Management first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 176 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.